Interactive Data Visualization Tool Connects Scientists Worldwide with Vital COVID-19 Research Data
|
By HospiMedica International staff writers Posted on 01 Jul 2020 |

Image: Zoic Labs’ visualization tool (Photo courtesy of Zoic Labs LLC)
An interactive data visualization tool connecting scientists with critical research while they work towards a cure for COVID-19 could quicken the pace of vital global scientific collaboration amidst the pandemic.
The tool for advanced data visualization on a series of scientific papers has been developed by Zoic Labs LLC (Dr. Culver City, CA, USA) which has implemented rich visual interactivity to allow global scientists dynamic ways to visually connect with the research. The innovative visualization and collaboration tool allows scientists around the world to share their findings and characterizes critical connections between the 27 SARS-CoV-2 proteins and the 332 human genes they interact with, lending a wealth of information about each gathered through research. The tool also provides in-depth knowledge about all current drug interactions and their statuses, and links to external sources for additional information about the virus proteins.
Zoic Labs has incorporated three additional disparate data sets to the existing map, which enabled interactively sharing information across five data sets. The new research characterizes the differences between normal SARS-CoV-2 infected cell signaling and phosphorylation dynamics, allowing a better understanding of the cellular pathways the virus needs to survive. Coupled with its SARS-CoV-2 protein-protein-interaction network, Zoic Labs’ visualization tool could be helpful in understanding the virus on a molecular level.
Related Links:
Zoic Labs LLC
The tool for advanced data visualization on a series of scientific papers has been developed by Zoic Labs LLC (Dr. Culver City, CA, USA) which has implemented rich visual interactivity to allow global scientists dynamic ways to visually connect with the research. The innovative visualization and collaboration tool allows scientists around the world to share their findings and characterizes critical connections between the 27 SARS-CoV-2 proteins and the 332 human genes they interact with, lending a wealth of information about each gathered through research. The tool also provides in-depth knowledge about all current drug interactions and their statuses, and links to external sources for additional information about the virus proteins.
Zoic Labs has incorporated three additional disparate data sets to the existing map, which enabled interactively sharing information across five data sets. The new research characterizes the differences between normal SARS-CoV-2 infected cell signaling and phosphorylation dynamics, allowing a better understanding of the cellular pathways the virus needs to survive. Coupled with its SARS-CoV-2 protein-protein-interaction network, Zoic Labs’ visualization tool could be helpful in understanding the virus on a molecular level.
Related Links:
Zoic Labs LLC
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Critical Care
view channel
Smartphone Imaging System Enables Early Oral Cancer Detection
Oral cancer is often diagnosed at an advanced stage, reducing survival rates despite the mouth’s easy accessibility for visual exams. Many dentists and hygienists can identify abnormal lesions but lack... Read more
Swallowable Pill-Sized Bioprinter Treats GI Tract Injuries
Soft tissue injuries in the gastrointestinal tract, such as ulcers and hemorrhages, are typically treated through invasive surgical procedures that carry high risks and do not always result in permanent repair.... Read moreSurgical Techniques
view channel
Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read more
Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more








